Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: BIOLOGICAL: cytomegalovirus IE-1-specific cytotoxic T lymphocytes|BIOLOGICAL: cytomegalovirus pp65-specific cytotoxic T lymphocytes|BIOLOGICAL: therapeutic allogeneic lymphocytes|GENETIC: polymerase chain reaction|OTHER: flow cytometry|OTHER: immunological diagnostic method|OTHER: laboratory biomarker analysis
Sponsor: Milton S. Hershey Medical Center
Collaborators: National Cancer Institute (NCI)